The pathogenesis of pulmonary fibrosis: a moving target.
about
Recent advances in understanding idiopathic pulmonary fibrosisRoflumilast Prevents the Metabolic Effects of Bleomycin-Induced Fibrosis in a Murine ModelNrf2 inhibits epithelial-mesenchymal transition by suppressing snail expression during pulmonary fibrosisA prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis.Treatment effects of the traditional Chinese medicine Shenks in bleomycin-induced lung fibrosis through regulation of TGF-beta/Smad3 signaling and oxidative stress.Clinical observation of umbilical cord mesenchymal stem cell treatment of severe idiopathic pulmonary fibrosis: A case report.Key roles for the small leucine-rich proteoglycans in renal and pulmonary pathophysiologyHGF Expressing Stem Cells in Usual Interstitial Pneumonia Originate from the Bone Marrow and Are Antifibrotic.Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosisImmune Inflammation and Disease Progression in Idiopathic Pulmonary Fibrosis.Differential telomerase expression in idiopathic pulmonary fibrosis and non-small cell lung cancer.Regulatory mechanisms of TGF-β1-induced fibrogenesis of human alveolar epithelial cells.Docosatetraenoyl LPA is elevated in exhaled breath condensate in idiopathic pulmonary fibrosis.Prevention of Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice by PaeonolYear in review 2013: Acute lung injury, interstitial lung diseases, sleep and physiology.Amelioration of bleomycin-induced pulmonary fibrosis by chlorogenic acid through endoplasmic reticulum stress inhibition.Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis.Thrombin Induces CCL2 Expression in Human Lung Fibroblasts via p300 Mediated Histone Acetylation and NF-KappaB Activation.Secreted frizzled related proteins inhibit fibrosis in vitro but appear redundant in vivo.The SPARC protein: an overview of its role in lung cancer and pulmonary fibrosis and its potential role in chronic airways disease.Multipotent mesenchymal stem cells in lung fibrosis.Involvement of ER stress, PI3K/AKT activation, and lung fibroblast proliferation in bleomycin-induced pulmonary fibrosis.An Improved Method for Rapid Intubation of the Trachea in Mice.Autophagy and inflammation in chronic respiratory disease.Circulating Mitochondrial DNA as a Mechanism-based, Prognostic Biomarker for Idiopathic Pulmonary Fibrosis.Short telomere length in IPF lung associates with fibrotic lesions and predicts survival.Nrf2 antioxidant pathway suppresses Numb-mediated epithelial-mesenchymal transition during pulmonary fibrosis.Macrophage migration inhibitory factor in lung tissue of idiopathic pulmonary fibrosis patients.Rapamycin protects against paraquat-induced pulmonary epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis.Combination of Salvia miltiorrhiza and ligustrazine attenuates bleomycin-induced pulmonary fibrosis in rats via modulating TNF-α and TGF-β.TGF beta inhibits HGF, FGF7, and FGF10 expression in normal and IPF lung fibroblasts
P2860
Q26745905-85871117-8A2A-4E2D-AB5F-2C17EB4B55DBQ28383918-4BCA6932-2D60-4640-9BAC-CA1EE3AD5833Q28396556-F49B32B6-D4ED-488E-A96C-456F2607C1B7Q30541785-9C8A20CD-E2A6-410C-AB9A-2DADAE99185AQ33714877-D0FBE93A-71CA-4291-8F69-E9FEB5DE7EC2Q33724205-70535EDD-A984-4DF8-9A71-B1FC31A8586EQ33819300-F706093A-5B59-4AB9-AE25-B94BFBBDD8D7Q34804461-BC70E419-6C42-4953-833B-18C218AB769DQ35558781-FD2799B0-7EB5-4FA1-8B88-8ED641A03E56Q36012118-D4489B16-F072-46C8-8357-CCE9341D1C16Q37341340-F8087AEA-39E8-4613-9251-5650F1679B43Q37370819-E68B1503-A759-4DEC-A083-80E0088DBBC6Q37532276-8E026D74-1254-42BA-9658-370A1FCAC8DBQ37731036-1DBF642C-838C-4051-8FCF-15A1CE0A38D4Q38202679-08492CD3-F9E7-4C1E-8F36-62931DFBFB2FQ38698129-3DE28380-8023-4B5E-AD04-64249BD57670Q38835390-7FCE539F-5ADC-4B9F-8E3E-9B72DD31D106Q38838136-923E13CF-F1E8-4070-9808-63D5DBF0D275Q38947751-6F53E46E-505B-40DE-B825-DC3533B59055Q38985417-E72EA5BC-701F-40A7-AC85-DCA0CD6270D6Q41474873-CA57BEA2-A623-4C89-B034-D43860C6A3E1Q43121294-27F085B3-DBB5-423F-9532-E1AC42883C60Q47578773-8A76E1A2-80E5-4143-A23C-4E11691A64B7Q47663797-3D88CB7E-FF48-42BA-8A09-D71D1E83A4A3Q48231065-5C5F52AD-93B4-4E58-886E-8D494D505CC1Q48342417-769D1394-0EFF-4905-8B5C-ED40AF4DC574Q49838896-FA324F38-7B07-4A75-88B5-A96677EE7E90Q51502645-5A7E9FD2-0F81-4530-89C0-375FE1C407A4Q54093489-B066DFC7-D1E8-43D6-9206-8186599ACBC5Q55379594-C35FF4FF-E455-4BF6-AC59-241F330304A6Q55613104-F23D40DF-67F2-4B1F-9707-5A57A8455F3BQ58699784-B2517B37-7D41-4E56-ADAF-86E2B5E5DFB0
P2860
The pathogenesis of pulmonary fibrosis: a moving target.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The pathogenesis of pulmonary fibrosis: a moving target.
@en
type
label
The pathogenesis of pulmonary fibrosis: a moving target.
@en
prefLabel
The pathogenesis of pulmonary fibrosis: a moving target.
@en
P2093
P50
P1476
The pathogenesis of pulmonary fibrosis: a moving target.
@en
P2093
Antje Prasse
Athol U Wells
Bart N Lambrecht
Carlos Robalo-Cordeiro
Eric Verbeken
Geert M Verleden
Helen Parfrey
Jim J Egan
Johny A Verschakelen
Katerina M Antoniou
P304
P356
10.1183/09031936.00073012
P577
2012-10-25T00:00:00Z